Company intelligence / Profile preview

Cagent Vascular

Wayne, Pennsylvania, United Statescagentvascular.com ↗

Ownership: Private
Development stage: Other

Overview

The Serranator PTA Serration Balloon Catheter has been used in over 10,000 procedures for PAD. Clinical data and physician feedback indicate the technology provides predictable lumen gain at lower pressures with reduced risk of arterial dissection compared to conventional angioplasty balloons. The company continues to expand clinical studies and commercial reach.

Therapeutic areas: Cardiovascular
Modalities: DeviceMedical device (angioplasty balloon)
Industry: Surgical Medical Devices

Partnerships

Strategic partnership with 3comma Medical for international distribution in EU and MENA regions

Beyond the preview

Go deeper on Cagent Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cagent Vascular.

Explore the full profile